The Preferred Biotech Resource in Asia-Pacific
Vol 19, No 07, July 2015
Biotech in China
Kh-biotech cover

Featured
Interviews

Eye on China

Columns

Conferences ListingConferences
Listing

e-alerts
Pharma Sales
BIOBOARD - EUROPE
GE Healthcare Life Sciences opens new £3 million laboratories for cell science
G E Healthcare Life Sciences, a business unit of GE Healthcare announced the opening of its new £3 million cell science laboratories in Cardiff, Wales.  The state-of-the-art investment at the company’s Maynard Centre creates a world-class facility for research and technology innovation in cell science, to help advance the rapidly emerging fields of cell therapy and cell bioprocessing, and to support the development of new, more effective and safer medicines.   The new laboratories, which will employ 43 scientists and technical support staff, were officially opened yesterday by the First Minister of Wales, the Rt. Hon. Carwyn Jones, AM.

 Dr Amr Abid, General Manager of Cell Technologies, GE Healthcare Life Sciences said, “Cellular research has an extraordinary potential to address some of the world’s biggest healthcare challenges.  Our investment in these new laboratories is a great milestone and demonstrates our commitment to innovation and excellence in cellular science.  Here in Cardiff we have established an outstanding team of scientists, many of whom are leaders in their field, and these new facilities will allow us to greatly expand our work.”

 The laboratories will focus on the development of novel technologies for the rapidly emerging field of cell therapy and on advancing new cellular based tools to help pharmaceutical companies develop better and safer medicines at lower cost.  The new facility is equipped with the latest technologies for cell bioprocessing and cell imaging, as well as an industry-leading clean-room manufacturing facility.  In addition, GE’s customers and scientific collaborators will benefit from an advanced technical training centre.  

 First Minster Carwyn Jones said: “It is great to see a global company locating its worldwide centre of excellence for cell technologies here in Wales. GE’s investment demonstrates that Wales has the right environment for world standard R&D in Life Sciences, and that Welsh Universities are attractive partners for industry at this level and scale.

 “Cell technology is one of the most exciting areas in life sciences today. The work undertaken here in Wales by GE Healthcare will support the development of new, safer medicines and drive the continued development of cell therapy and regenerative medicine.”

Click here for the complete issue.